A recent study conducted by Future Market Insights (FMI) reveals a promising outlook for the global protein A resins market, with projections indicating significant growth over the next decade. Valued at USD 677.84 million in 2023, the market is anticipated to almost double, reaching an estimated USD 1,477.01 million by 2033, propelled by a robust compound annual growth rate (CAGR) of 8.1%.
Protein A resins play a pivotal role in the purification processes required for the production of monoclonal antibodies. These antibodies are becoming increasingly essential in therapeutic treatments and diagnostics, underlining the rapid expansion of the sector. The surging prevalence of chronic diseases, the thriving biopharmaceutical industry, and continuous advancements in clinical research methodologies are key factors driving the growing demand for more effective biologics.
“The global protein A resins market is poised for substantial growth in the coming years,” stated Future Market Insights. “This growth is driven by the escalating demand for monoclonal antibodies in therapeutic applications, coupled with advancements in biopharmaceutical production techniques.”
The study highlights that North America currently holds a significant share of the protein A resins market, attributed to the strong presence of biopharmaceutical companies and considerable investments in healthcare research and development. However, the Asia-Pacific region is expected to experience the highest growth rate during the forecast period, supported by increasing healthcare expenditures and expanding biopharmaceutical manufacturing capabilities in countries such as China and India.
As the global healthcare landscape continues to evolve, the protein A resins market is set to play an increasingly critical role in supporting the development and production of life-saving biologics. This robust growth trajectory underscores the vital importance of protein A resins in the advancement of biopharmaceutical innovations, positioning the market for sustained expansion over the next decade.
Factors Contributing to the Rise of CMOs in mAb Production:
- Limited In-House Capabilities: Many biotechnology companies lack the internal infrastructure and expertise required for mAb production.
- Supply Chain Complexity: Managing the complex supply chain associated with mAb manufacturing can be challenging.
- High Financial Investment: Establishing high-containment biologic facilities requires significant financial resources, posing a risk for individual companies.
Therefore, the outsourcing of mAb development and manufacturing to CMOs is expected to create a substantial demand for protein A resins, further propelling market growth.
This highlights the projected growth of the protein A resins market, driven primarily by the increasing demand for monoclonal antibody production and the crucial role played by Contract Manufacturing Organizations.
Top Highlights from the FMI’s Analysis of the Protein A Resins Market:
- The United States protein A resins industry is expected to acquire more than 93.5% value share of the North America market.
- Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
- The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
- High demand for natural protein A resin is expected to yield a large market share in 2023.
- Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
- The antibody purification segment is projected to gain 74.8% of the global market.
- The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.
Key Players in the Market are:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
Protein A Resins Market by Category:
Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
Matrix:
- Agarose-based Matrix
- Glass or Silica-based Matrix
- Organic Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody Purification
End User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube